TABLE 2

Recommended Follow-up Period (days) on the Basis of Clinical Risk Index Score TSB and TcB Risk Group Measurements

Clinical Risk Index ScoreTSB or TcB Risk Group
LowLow-IntermediateHigh-IntermediateHigh
≥151–2111
10–141–31–211
5–9a1–31–21
<5aa1–31
  • TSB levels were recommended if TcB values were ≥15 mg/dL or within 3 mg/dL of the AAP phototherapy. Bilirubin values were plotted on the nomogram described by Bhutani et al6 to determine risk group.

  • a Very low risk of significant jaundice, but follow-up evaluation for other reasons may be required.